CM LIFE SCIENCES, INC.

Company

GeneDx Holdings Corp.

Filed

September 11, 2020

Accession Number

0000902664-20-003294

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →